Abstract
This survey study assesses vaccination intentions of unvaccinated US adults in response to full US Food and Drug Administration (FDA) approval of the BNT162b2 (Pfizer-BioNTech) COVID-19 vaccine and any demographic characteristics associated with those intentions.
For the full article, please visit https://pubmed.ncbi.nlm.nih.gov/35404416/